A159 ANTI-TUMOR NECROSIS FACTOR THERAPY PERSISTENCE IN PATIENTS WITH PERIANAL CROHN’S DISEASE AND LUMINAL CROHN’S DISEASE: A COMPARATIVE COHORT STUDY

BACKGROUND: Anti-tumor necrosis factor therapy has revolutionized the management of Crohn’s disease. Despite its effectiveness, a substantial proportion of patients discontinue therapy over time. Evaluating drug persistence rates reveals a real-world pattern of biologic use. Perianal Crohn’s disease...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:J Can Assoc Gastroenterol
Egile Nagusiak: Fung, M, Chin Koon Siw, K, McCurdy, J D
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Oxford University Press 2021
Gaiak:
Poster of Distinction
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7958712/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jcag/gwab002.157
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak